President Piñera presents the National Drug Policy that facilitates access, quality, and reduces costs.

Chile Sebastián Piñera · President of Chile

7 October 2019

Context
Piñera announced Chile's National Drug Policy in October 2019, outlining 30 measures to reduce medication prices, improve access, and ensure quality for Chileans.
Main themes
Drug pricing reform, medication access, bioequivalent medications, chronic disease management, elderly healthcare, national drug policy, pharmacy regulation, out-of-pocket health costs, public health strengthening, pharmaceutical affordability
Duration
~15 min
51st percentile
Words
1,774
51st percentile
Sentences
66
43rd percentile
Readability
41
39th percentile
Grade
14.2
69th percentile
Syntax
3.23
76th percentile
Vocabulary
2.19
46th percentile

Translated from Spanish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 36%36%
  • Social 29%29%
  • Institutional 15%15%
  • Technological 14%14%
  • Ceremonial 6%6%
  • Geopolitical 0%0%
  • Environmental 0%0%
  • Not in focus 0%

66 sentences in 38 paragraphs

Good morning:

Medications in Chile are expensive, too expensive, and that has to change. It is clear that there is responsibility on the part of the laboratories that sometimes charge more in Chile than in other countries, and a clear responsibility of the pharmacies that often do not comply with the law.

For example, a recent study by SERNAC shows that too many pharmacies do not have available the bioequivalent medications that, according to the law, they should have. In addition to other bad practices.

I want to say that, in this matter, the attitude of the Government, and I also know of the parliamentarians who are promoting the laws, is total and definitive. We will not continue to allow abuses against Chileans, because we know very well that Chileans spend a lot of money on medications. In fact, we are here to implement and promote this National Medication Policy that, through 30 measures, seeks to reduce the price of medications for people.

We know that in our country the population is aging, because fewer children are being born, because we live longer, but that means a very profound change in health needs and demands and in epidemiology. And among these, chronic diseases are growing very strongly. Unlike diseases in younger populations that can be cured, diseases in older populations are chronic: diabetes, hypertension, cholesterol, depression.

These chronic diseases require permanent medications and, therefore, those who use medications the most are the elderly, who are more prone to these chronic diseases, and those who suffer the most from high medication prices are the elderly, the most vulnerable sectors, and our middle class. And it is for them that we are gathered here.

Chronic diseases represent about 80% of the health burden in our country and require lifelong medication. In fact, the elderly consume an average of 5 different medications every day, and for that reason, the price of medications directly affects the quality of life of everyone, but especially the elderly, the chronically ill, the most vulnerable sectors, and our middle class.

Spending on medications represents between 32% and 35% of out-of-pocket health expenses for people and, therefore, it is a fundamental item. And for that reason, we have decided - with the strong support of the deputies and senators - to vigorously promote this National Agenda to reduce the price of medications; to facilitate access - I want to remind you that in Chile there are more than 57 communes that do not have any pharmacy - and to ensure their quality. And that is why we are strengthening the Public Health Institute.

We must make every effort so that the remedy is not worse than the disease, and that is why it is very important that this law is promoted with a great agreement in Parliament.

The objectives are clear: facilitate access, reduce the price of medications, and guarantee their quality.

What are some of the measures included in this plan? There are 30 measures; I will mention only a few of them:

First, increase the number of active ingredients with demonstrated bioequivalence, so that people have the ability to choose. It is absurd what we read constantly, that a brand-name medication can cost 10 or 100 times more than a certified bioequivalent medication. They have the same therapeutic effect, and yet they have a very different impact on people's wallets.

And for that reason, this law promotes a greater number of bioequivalent products so that people have options and know that when the color is yellow, it is because the therapeutic effect is exactly the same, even though the name and packaging are different.

So let us seek and choose the yellow color that means bioequivalent, because that will protect our health and heal our wallets;

Second, pharmacies will be required to have a sufficient minimum stock of bioequivalent medications, and those that do not comply - and I want to say this very clearly - better think ten times, because the punishment will be very severe, because we will not allow them to continue abusing people through various subterfuges;

The delivery of medications to the home for people with severe dependence, who are monitored in Primary Care Centers. This year we will start with 10 communes in the country, but we will expand it to as many communes as possible so that people with severe dependence can receive their medications at home;

Fourth, the delivery of medications for adults in ELEAM (Long-Stay Establishments) and in Day Centers, which is a great opportunity for the elderly to receive medications in those centers;

Fifth, Pharmaceutical Stores in all communes that have municipal health and do not have a pharmacy, so that no person in any commune in Chile cannot supply and access medications in a normal way;

Sixth, the Digital Pillbox, which is a mobile application that will help patients remember when to take their medication. Technology allows us to send a personalized message to each patient, reminding them that it is time to take their medication;

Seventh, a regulation to allow and facilitate the Electronic Sale of Medications to guarantee more offers, more competition, and therefore more benefits and lower prices for people.

Eighth, a Price Comparator that will be part of the Digital Hospital. The law establishes that pharmacies will be obliged to inform their prices online and electronically to the Ministry of Health, and that will feed into the information system of the Digital Hospital. And, therefore, everyone will be able to easily compare, without having to go from pharmacy to pharmacy, which medications are available, what prices they have, which are the bioequivalents, and therefore buy in an informed manner.

And I take this opportunity to say, the Digital Hospital is a great advance, it is technology at the service of people. And, therefore, the Digital Hospital is a project that is being promoted, which will continue to be promoted with all the strength of our Government.

In addition to this price comparator, which will be a great tool at the service of people to prevent the lack of information and opacity from allowing abuses against Chileans, we will also allow direct importation through a specific authorization from the Public Health Institute for those who can and need to do so.

But there is more, also measures that directly aim to reduce prices. The bidding of medications by FONASA; we made a bid for FONASA to provide benefits to its users. It is curious, FONASA has 13 million affiliates and had not managed to reach a favorable agreement with pharmacies. We have it, which means an average cost saving of 28%, it is in effect in a number of communes and we will extend it to the entire country. And that means, directly, a reduction in the price of medications. In many cases, families will be able to save up to 50,000 pesos monthly as a result of this agreement between FONASA and some pharmacies.

Another measure, the obligation for the pharmaceutical industry to implement the Medication Fractionation System and not have to buy two or three times more than what one needs. That is another measure that directly aims to lower prices.

Establish new import agreements for medications through CENABAST, such as the agreement we just made with India. India is a global power in its pharmaceutical industry, it has an industry whose products are certified in the most sophisticated and demanding economies and societies in the world, and the prices are much lower than what we know in Chile.

And I want to remind you that Prime Minister Modi personally committed to me in the meeting we had in Osaka to accelerate and he kept his word.

The Drug Law II, which is currently in Congress and which we will give utmost urgency so that, once and for all, it sees the light of day and manages to overcome these forces that, one way or another, are constantly trying to stop it.

And, therefore, this law will allow the patient to choose which medication to take among all those that have the same prescribed active ingredient and have bioequivalence. In this way, we give patients a way to protect themselves against those who want to overcharge for a brand-name medication, when there is another bioequivalent that is much cheaper.

The Protected Middle Class Project that incorporates a Catastrophic Health Insurance, what does that mean? That people will know, both in FONASA and in ISAPRE, that in the face of an illness there is a maximum expense and from there on, the responsibility is no longer of the person or the patient, but is assumed socially by the State or by society to give peace of mind and security that a serious illness will not only affect their health but will not also destabilize their finances.

On the other hand, the update of the “Ricarte Soto” Law;

The International Price Observatory to constantly compare the prices at which laboratories sell in Chile with what those same laboratories sell those same medications in other countries of the world. Very useful information when we have to negotiate the purchase of medications.

The Homologation of Bioequivalence when they have been homologated by first-class agencies such as the Food and Drug Administration of the United States or its equivalent in Europe, in order to accelerate the process by which we incorporate more bioequivalent products and thus protect our consumers, our patients, our elderly, our sick, our most vulnerable sectors, our middle class.

Because choosing yellow means that it will have the same therapeutic effect on your health, the same, that is certified by the Public Health Institute, but it will have a very significant effect on paying less for the medications you need.

Therefore, the mandate, Minister Mañalich, is strong and clear from this law: facilitate access - for many people it is very difficult to access medications - reduce the prices of medications, and ensure, of course, the quality and therapeutic effect of those medications.

To that we add the push for the Digital Hospital, which is a central issue because technology must be at the service of people in what they need most, and we have the technology that allows, through the Digital Hospital, to reach all corners of Chile, so that where the treating physician is, their patient can have direct contact with a specialist doctor and, therefore, make more accurate diagnoses, more effective treatments; it is a powerful tool that technology gives us and that we will use to its fullest extent.

And finally, as Greta Thunberg said, Minister: “I’ll be watching you.”

Thank you very much.